Streamline Stability Decisions in Pharmaceutical Development
Stability decisions in pharmaceutical development require extensive data, often scattered across incompatible systems. For scientists, this complicates analysis, increases errors, and hinders collaboration. Luminata® streamlines forced degradation and accelerated predictive stability (APS) studies by consolidating data into a chemically intelligent platform, enabling efficient analysis and informed decision-making. Join this webinar to see how Luminata accelerates...
The Implementation and Impact of Chemical High-Throughput Experimentation at AstraZeneca
High-throughput experimentation (HTE) is a critical tool in modern pharmaceutical discovery and development. The ability to perform multiple parallel experiments in miniaturized plate-based formats has revolutionized how chemical reactions are optimized. HTE has been especially enabling for catalytic reactions, where the complexity of factors influencing the outcome makes the HTE approach especially suitable. We detail...